ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NGEN Nervgen Pharma Corporation

2.08
-0.12 (-5.45%)
May 21 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 31k00000
Operating Income -1.36M-8.4M-9.93M-11.14M-21.98M-16.94M
Pre Tax Income -1.36M-9.77M-11.19M-12.73M-20.72M-22.38M
Net Income -1.36M-9.77M-11.19M-12.73M-20.72M-22.38M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.079-0.333-0.318-0.276-0.353-0.375
EBIT -1.36M-8.4M-9.93M-11.14M-21.98M-16.94M
EBITDA -1.34M-8.36M-9.89M-11.1M-21.86M-16.79M

Your Recent History

Delayed Upgrade Clock